We use cookies on this website. By continuing to use this site without changing your cookie settings, you agree that you are happy to accept our cookies and for us to access these on your device. Find out more about how we use cookies and how to change your cookie settings.

New and renewed Senior Fellows

1 March 2010

Mast cells
News about Wellcome Trust Senior Fellows researching mast cell signalling, genetics, stem cell research and parasitology.

Our International Senior Research Fellowships launched in selected European countries in 2002. In Hungary, Dr Attila Mocsai from the Department of Physiology at Semmelweis University is the first recipient to have his Fellowship renewed. His research looks at mast cell signalling (frequently involved in allergic reactions) and how this affects non-allergic inflammation.

In the UK, Mark Jobling, Professor of Genetics at the University of Leicester and a former Research Career Development Fellow, has had his Senior Research Fellowship in Basic Biomedical Science renewed for a second time.

Meanwhile, two new Senior Research Fellowships in Biomedical Science have brought two scientists from Europe to conduct research in the UK. Dr Anton Wutz has travelled from Austria to join the Wellcome Trust Centre for Stem Cell Research in Cambridge, where he will study how changes in cellular identity are regulated when stem cells differentiate.

Dr Markus Meissner has moved from Germany to the Wellcome Trust Centre for Molecular Parasitology at the University of Glasgow, where he will investigate the parasitic organism Toxoplasma gondii and its highly specific way of invading cells.

The 2010/11 competitions for our International Senior Research Fellowships and Senior Research Fellowships in Basic Biomedical Science open again in June.

Image: Mast cells are involved in allergic reactions. Credit: University of Edinburgh

Share |
Home  >  News and features  >  2010  > New and renewed Senior Fellows
Wellcome Trust, Gibbs Building, 215 Euston Road, London NW1 2BE, UK T:+44 (0)20 7611 8888